148 related articles for article (PubMed ID: 26811000)
1. Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas.
Xiao D; Shi Y; Fu C; Jia J; Pan Y; Jiang Y; Chen L; Liu S; Zhou W; Zhou J; Tao Y
Leuk Res; 2016 Mar; 42():75-9. PubMed ID: 26811000
[TBL] [Abstract][Full Text] [Related]
2. Granulocytic sarcomas: difficulties in diagnosis.
Markoc F; Bozdogan N; Yükrük FA; Gumuc EB; Akdur NC
Tumori; 2010; 96(1):149-53. PubMed ID: 20437873
[TBL] [Abstract][Full Text] [Related]
3. Assessment of PET/CT in multifocal myeloid sarcomas with loss of TET2: a case report and literature review.
Pan Y; Tao Y; Fu C; Jia J; Liu S; Xiao D
Int J Clin Exp Pathol; 2015; 8(10):13630-4. PubMed ID: 26722587
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic and immunophenotypic analysis of myeloid sarcoma].
Li JM; Liu WP; Zhang MH; Wei X; Gu JM; Han AJ; Wu WQ; Chen XY
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):606-11. PubMed ID: 17134569
[TBL] [Abstract][Full Text] [Related]
5. State of the art in myeloid sarcoma.
Klco JM; Welch JS; Nguyen TT; Hurley MY; Kreisel FH; Hassan A; Lind AC; Frater JL
Int J Lab Hematol; 2011 Dec; 33(6):555-65. PubMed ID: 21883967
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed, paraffin-embedded tissue.
Hudock J; Chatten J; Miettinen M
Am J Clin Pathol; 1994 Jul; 102(1):55-60. PubMed ID: 8037168
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.
Chang CC; Eshoa C; Kampalath B; Shidham VB; Perkins S
Am J Clin Pathol; 2000 Nov; 114(5):807-11. PubMed ID: 11068557
[TBL] [Abstract][Full Text] [Related]
8. Myeloid Sarcoma of the Testis in Children: Clinicopathologic and Immunohistochemical Characteristics With KMT2A (MLL) Gene Rearrangement Correlation.
El Jamal SM; Salama A; Marcellino BK; Abulsayen HA; Zhou X; Hassan M; Firpo-Betancourt A; Saad AG
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):501-507. PubMed ID: 31241561
[TBL] [Abstract][Full Text] [Related]
9. c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma.
Chen J; Yanuck RR; Abbondanzo SL; Chu WS; Aguilera NS
Arch Pathol Lab Med; 2001 Nov; 125(11):1448-52. PubMed ID: 11698000
[TBL] [Abstract][Full Text] [Related]
10. [Myeloid sarcoma of the brain. A case report].
Jabri L; Karkouri M; Zamiati S; Sqalli S; Iraqi A
Ann Pathol; 2003 Feb; 23(1):59-61. PubMed ID: 12743502
[TBL] [Abstract][Full Text] [Related]
11. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117, and myeloperoxidase.
Dunphy CH; Polski JM; Evans HL; Gardner LJ
Arch Pathol Lab Med; 2001 Aug; 125(8):1063-9. PubMed ID: 11473459
[TBL] [Abstract][Full Text] [Related]
13. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.
Scopim-Ribeiro R; Machado-Neto JA; de Melo Campos P; Niemann FS; Lorand-Metze I; Costa FF; Olalla Saad ST; Traina F
Diagn Pathol; 2016 Mar; 11():28. PubMed ID: 26984174
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and differential diagnosis of granulocytic sarcomas].
Liu YH; Zhuang HG; Liao XB; Luo XL; Cai XL; Luo DL
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):568-71. PubMed ID: 14720440
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.
Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ
Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
[TBL] [Abstract][Full Text] [Related]
17. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
[TBL] [Abstract][Full Text] [Related]
18. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
[TBL] [Abstract][Full Text] [Related]
19. ERG Immunoreactivity in Blastic Hematolymphoid Neoplasms: Diagnostic Pitfall in the Workup of Undifferentiated Malignant Neoplasms.
Koo M; Natkunam Y
Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):42-48. PubMed ID: 34261976
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Zhang LY; Li PL; Wang TZ; Zhang XC
Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
